top of page

Aries Biotech Partners with NeuroTheranostics, Inc.

Peptide-based Strategies for Healing Neurological Damage

Aries Biotech and NeuroTheranostics are merging their collective expertise in research and development to address potential impact of synthetic, protease-targeting compounds upon the central nervous system. These strategies have the potential to mitigate a broad spectrum of injuries and diseases.

To learn how we can assist with your needs within science and medicine, visit Aries Biotech at

39 views0 comments

Recent Posts

See All

Thank you - Alzheimer’s Research UK!

Aries Biotech extends gratitude to the Alzheimer’s Research UK team, for inviting Dr. Angela Boutte, the founder of Aries Biotech, as a contributing reviewer and panelist. Through partnerships with th


bottom of page